Acne is one of the most common skin disorders in the United States, currently, affecting almost 40 - 50 million Americans, annually. The American Academy of Dermatology states that approximately 85% of people between the ages of 12 and 24 yearsâ€™ experience at least minor acne. The costs associated with the treatment of acne currently exceed USD 3 billion. The acne market awaits a blockbuster drug; most of the current pipeline products consist of combination products with very few first-in-class molecules. Emerging products are also not significantly different from the current monotherapies.
Global Acne Therapeutics - Market Dynamics
The report details several factors driving and restraining the market, some of which are discussed below.
Increasing sedentary lifestyle and unhealthy food habits
Rise in disposable income of consumers
Increasing awareness about current and upcoming acne treatments
High global acne prevalence
The safety issues regarding the products
Entry of Generics in the acne treatment drug market
The global acne therapeutics market has been segmented by treatment into therapeutics and other treatments. The therapeutics segment is further segmented into antibiotics (erythromycin and clindamycin), retinoid (adapalene, tazaroteen, tretinoin and isotretinoin), combination medications, anti-inflammatory, hormonal agents and other agents (azelaic acid and resorcinol). Other treatments include laser and light therapy, cosmetic procedures and acne scar treatment. The market has been geographically segmented into North America, Europe, Asia-Pacific, and Rest of the World.
Major Companies in the Sector Include:
This Report Offers:
Market definition, along with identification of key drivers and restraints for the market.
Market analysis with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect the industry on both global and regional scale.
A comprehensive list of key market players, along with the analysis of their current strategic interests and key financial information.
An ideal source material for industry consultants, manufacturers and other interested and allied parties to gain critical insight into the factors driving and restraining the market, in addition to opportunities, offered.
1.1 Study Deliveratives
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
1.7 Report Description
2. RESEARCH METHODOLOGY
2.2 Analysis Methodology
2.3 Study Timeline
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering & Econometric Model
2.4.4 Expert Validation
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW AND INDUSTRY TRENDS
5.1 Current Market Scenario
5.2 Market Overview
5.3 Porters Five Force Analysis
5.3.1 Bargaining Power Of Suppliers
5.3.2 Bargaining Power Of Buyers
5.3.3 Degree Of Competition
5.3.4 Threat Of Substitution
5.3.5 Threat Of New Entrants
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 Market Drivers
6.1.1 Increasing Sedentary Lifestyle and Unhealthy Food Habits
6.1.2 Rise in Disposable Income of Consumers
6.1.3 Increasing Awareness About Current and Upcoming Acne Treatments
6.1.4 High Global Acne Prevalence
6.2 Market Restraints
6.2.1 The Safety Issues Regarding the Products
6.2.2 The Entry of Generics in the Acne Treatment Drug Market
6.3 Market Opportunities
6.4 Key Challenges
7. Global Acne Therapeutics Market - Segmentation
7.1 BY TREATMENT
18.104.22.168 Retinoid (Adapalene, Tazaroteen, Tretinoin and Isotretinoin)
22.214.171.124 Antibiotics (Erythromycin and Clindamycin)
126.96.36.199 Hormonal Agents, Combination Medications, Anti-Inflammatory
188.8.131.52 Other Agents (Azelaic Acid and Resorcinol)
7.1.2 Others(laser & light therapy, cosmetic procedures acne scar treatments)
8. Global Acne Therapeutics Market - Regional Shares and Forecast
8.1 North America
8.1.1 United States
8.2.5 Spain & Portugal
8.2.8 Rest of Europe
8.3.4 Australia & New Zealand
8.3.5 South Korea
8.3.6 Rest of Asia-Pacific
8.4 The Middle East and Africa
8.4.2 South Africa
8.4.3 Rest of the Middle East and Africa
8.5 Latin America
8.5.3 Rest of Latin America
9. Competitive Landscape
9.1 Merger and Acquisition Analysis
9.2 New Product Launches
9.3 Agreements, Collaborations & Partnerships
10. Company Profiles
10.3 Stiefel Laboratories, Inc.
10.4 Valeant Pharmaceutical International Inc.
10.5 Johnson & Johnson Private Limited
10.10 Bayer AG
11. Analyst Outlook for Investment Opportunities
12. Future Outlook of the Market